Skip to main content
STIM $1.37 -1.44%
STIM logo
STIM · Neuronetics, Inc.
Track STIM — free
$1.37 -0.02 (-1.44%) Q1 2026 earnings call transcript
Market Cap
$108.04M
Shares
77.73M
Volume · Nov 13 16.26M Avg daily vol (3M) 1.64M
All webcasts

Earnings call · FY2026 Q2

Neuronetics, Inc. (STIM) Q2 2026 Earnings Call

Concluded Aug 11, 2026
Aug 11, 2026
Period
FY2026 Q2
Runtime
—
Sources
3 artifacts
Revenue $41.57M +9.1% YoY
Diluted EPS -$0.05
Gross margin 51.1% +4.5 pp YoY
Net income -$3.44M
Open full screen Slides 26 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.

Greenbrook clinic operational performance 32 Neurostar commercial model evolution 17 Path to profitability and cash generation 15 Revenue mix and gross margin drivers 15 Full-year guidance update 11 Cost discipline and OPEX reduction 10

Management tone

Positive

Net tone +45 · low hedging

Grounding quotes
  • “we grew revenue, improved our margins, reduced our cash burn, and strengthened our balance sheet, all while continuing to invest in the growth of the business”
  • “We also began using AI in the insurance authorization process, which has helped us reduce operating costs”
  • “Net loss for the quarter was $3.4 million, or $0.05 per share, compared to a net loss of $10.1 million, or $0.15 per share in the prior year”
  • “our session revenue was down double digits and our capital sales were up double digits”

Forward guidance

6 guided metrics

Management's latest ranges and targets are included below.

Research coverage

3 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Aug 11, 2026.

Metric Guided
Total revenue Lowered
full year 2026
$160M – $164M
Gross margin Raised
full year 2026
48% – 50%
Operating expenses Lowered
full year 2026
$95M – $100M
Operating expenses, less SBC
full year 2026
$91M – $96M
Operating Expenses
FY 2026
$91M – $96M
Cash Flow from Operations and Investing
FY 2026
$-14.5M – $-10.5M

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Greenbrook Segment$26.89M +16.8% YoY
Neurostar Segment$14.68M -2.7% YoY
Full-screen source Call document